Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
Clinical trial NCT06252649 · RECRUITING
Trial details
- NCT number
- NCT06252649
- Sponsor
- Amgen
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-17
- Primary completion
- 2028-09-25
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.